Psoriatic Arthritis Treatment Update

Focused on PsA treatment advancements, this session outlines best practices for APPs managing musculoskeletal disease. Faculty will review drug selection based on phenotype and disease activity. Attendees will learn when to initiate or taper therapy and how to integrate JAK inhibitors and biologics. Practical considerations for long-term monitoring will be discussed.